<DOC>
	<DOCNO>NCT01976624</DOCNO>
	<brief_summary>This study Post-Marketing Surveillance study evaluate safety efficacy bimatoprost/timolol ( Ganfort® ) Ophthalmic Solution treat open-angle glaucoma ocular hypertension Korea .</brief_summary>
	<brief_title>Safety Efficacy Bimatoprost/Timolol ( Ganfort® ) Ophthalmic Solution Korea</brief_title>
	<detailed_description />
	<mesh_term>Ocular Hypertension</mesh_term>
	<mesh_term>Glaucoma , Open-Angle</mesh_term>
	<mesh_term>Cloprostenol</mesh_term>
	<mesh_term>Timolol</mesh_term>
	<mesh_term>Bimatoprost</mesh_term>
	<mesh_term>Ophthalmic Solutions</mesh_term>
	<criteria>Patients treat Ganfort® openangle glaucoma ocular hypertension clinical practice .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2015</verification_date>
</DOC>